Literature DB >> 1580840

Familial optic atrophy with negative electroretinograms.

R G Weleber1, Y Miyake.   

Abstract

We describe optic atrophy and abnormal electroretinographic findings in affected members from two families. Central vision failed in the second to third decade of life. Examination findings included visual acuities of 20/20 (1.0) to 20/500 (0.4), defective color vision, mild to moderate myopia, pericentral or centrocecal scotomas, and, in four of five patients, optic atrophy. Dark adaptometry found elevated cone and rod psychophysical thresholds. Bright flash electroretinograms showed normal a-wave amplitude and markedly subnormal b-wave amplitude. Rod responses were low normal to moderately subnormal in amplitude with normal implicit times. Photopic electroretinographic b-wave amplitudes varied from normal to mildly subnormal. Cone implicit times were normal. Because negative electroretinograms are not seen with other familial optic atrophies, the association of optic atrophy with the abnormal negative electroretinogram configuration in these patients represents a newly appreciated genetic disorder.

Entities:  

Mesh:

Year:  1992        PMID: 1580840     DOI: 10.1001/archopht.1992.01080170062025

Source DB:  PubMed          Journal:  Arch Ophthalmol        ISSN: 0003-9950


  3 in total

1.  Optic atrophy and negative electroretinogram in a patient associated with a novel OPA1 mutation.

Authors:  Makoto Nakamura; Yozo Miyake
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2005-07-15       Impact factor: 3.117

2.  Duchenne muscular dystrophy: negative electroretinograms and normal dark adaptation. Reappraisal of assignment of X linked incomplete congenital stationary night blindness.

Authors:  H Jensen; M Warburg; O Sjö; M Schwartz
Journal:  J Med Genet       Date:  1995-05       Impact factor: 6.318

3.  A negative electroretinogram (ERG) in a case of probable multiple system atrophy (MSA).

Authors:  Claire S Barnes; Jiong Yan; George R Wilmot
Journal:  Doc Ophthalmol       Date:  2008-11-21       Impact factor: 2.379

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.